Why the study?
Does the urinary hydrochlorothiazide-creatinine ratio (UHCR) accurately measure compliance with hydrochlorothiazide therapy in healthy young men?
Does the urinary hydrochlorothiazide-creatinine ratio (UHCR) accurately measure compliance with hydrochlorothiazide therapy in healthy young men?
The urinary hydrochlorothiazide-creatinine ratio is a feasible and quantitative index for assessing compliance with hydrochlorothiazide therapy.
Answers are grounded in this paper and cite their sources.
UHCR may quantify hydrochlorothiazide compliance in healthy men; leaves open validation in hypertensive patients before clinical adoption.
We gave 21 healthy young men 100 mg of hydrochlorothiazide daily to determine whether or not urinary detection of the drug was feasible as a measure of compliance on a standard antihypertensive regimen. All subjects took the drug daily for 6 days, after which they were divided into four groups with differing patterns of medication administration. Urine hydrochlorothiazide and creatinine measurements were obtained to validate the urinary hydrochlorothiazide-creatinine ratio (UHCR) as an accurate quantitative index of compliance. The subjects achieved a constant level of UHCR of 13 +/- 3.0 within 48 hours of hydrochlorothiazide administration. The UHCR levels decreased to 5.0 +/- 0.8 48 hours after discontinuation of the drug (p less than 0.001). UHCR values in the range of 13 +/- 6 indicate that the subject has ingested hydrochlorothiazide 24 hours previously. The UHCR is a potentially useful means of assessing compliance in hypertensive patients taking hydrochlorothiazide.
No takes yet. Share an insight, caveat, or question.
Hodge et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: